Search

Your search keyword '"Service de néphrologie adultes [CHU Necker]"' showing total 44 results

Search Constraints

Start Over You searched for: Author "Service de néphrologie adultes [CHU Necker]" Remove constraint Author: "Service de néphrologie adultes [CHU Necker]"
44 results on '"Service de néphrologie adultes [CHU Necker]"'

Search Results

1. Allograft function and muscle mass evolution after kidney transplantation

2. COVID-19 outbreak in vaccinated patients from a haemodialysis unit: antibody titres as a marker of protection from infection

Catalog

Books, media, physical & digital resources

3. Temporal trends in living kidney donation in France between 2007 and 2017

4. Vascular access cannulation and haemostasis: a national observational study of French practices

5. Usefulness of morphometric image analysis with Sirius Red to assess interstitial fibrosis after renal transplantation from uncontrolled circulatory death donors

6. The tetraspanin CD9 controls migration and proliferation of parietal epithelial cells and glomerular disease progression

7. The cannabinoid receptor 1 is involved in renal fibrosis during chronic allograft dysfunction: Proof of concept

8. [In-hospital management of acute complicated urinary tract infections]

9. Diagnosis and management of asymptomatic bacteriuria in kidney transplant recipients

10. Efficacité et tolérance du fébuxostat chez 73 patients goutteux avec une insuffisance rénale chronique stade 4/5 : étude rétrospective de 10 centres

11. Targeted therapy in patients with PIK3CA-related overgrowth syndrome

12. Value of biomarkers for predicting immunoglobulin A vasculitis nephritis outcome in an adult prospective cohort

13. Efficacy and safety of febuxostat in 73 gouty patients with stage 4/5 chronic kidney disease: A retrospective study of 10 centers

14. Warfarin-related nephropathy induced by three different vitamin K antagonists: analysis of 13 biopsy-proven cases

15. Propensity score-based comparison of the graft failure risk between kidney transplant recipients of standard and expanded criteria donor grafts: Toward increasing the pool of marginal donors

16. Cryptosporidium spp. Infection in Solid Organ Transplantation

17. Characteristics and Management of IgA Vasculitis (Henoch-Schonlein) in Adults Data From 260 Patients Included in a French Multicenter Retrospective Survey

18. Risk of Aggressive Skin Cancers After Kidney Retransplantation in Patients With Previous Posttransplant Cutaneous Squamous Cell Carcinomas

19. Report on chronic dialysis in France in 2016

20. Genome-Wide Association Study of Acute Renal Graft Rejection

21. Traitement par tolvaptan dans la polykystose rénale autosomique dominante : aspects pratiques

22. PHENOTYPIC STUDY OF KIDNEY TRANSPLANT PATIENTS PRESENTING DE NOVO DSA: A FRENCH MULTICENTER COHORT OF 96 CASES

23. Generation of Catalytic Antibodies Is an Intrinsic Property of an Individual’s Immune System: A Study on a Large Cohort of Renal Transplant Patients

24. Prévention des infections au cours du lupus systémique chez l’adulte et l’adolescent : élaboration de recommandations pour la pratique clinique, à partir d’une analyse de la littérature et de l’avis d’experts

25. A lack of significant effect of POR*28 allelic variant on tacrolimus exposure in kidney transplant recipients

26. Long-term clinical impact of adaptation of initial tacrolimus dosing to CYP3A5 genotype

27. EPITOPE LOAD IS PREDECTIVE OF DE NOVO CLASS II DSA OCCURRENCE IN RENAL TRANSPLANT RECIPIENTS AFTER CONVERSION FROM CYCLOSPORINE TO EVEROLIMUS

28. Mutation Update of the CLCN5 Gene Responsible for Dent Disease 1

29. Restricted specificity of peripheral alloreactive memory B cells in HLA-sensitized patients awaiting a kidney transplant

30. Eight-year results of the Spiesser study, a randomized trial comparing de novo sirolimus and cyclosporine in renal transplantation

31. De Novo Donor-Specific Human Leukocyte Antigen Antibodies in Nonsensitized Kidney Transplant Recipients After T Cell-Mediated Rejection

32. Membranous Nephropathy Associated With Immunological Disorder-Related Liver Disease

33. Conversion from everolimus with low-exposure cyclosporine to everolimus with mycophenolate sodium maintenance therapy in kidney transplant recipients: a randomized, open-label multicenter study

34. Influence of Cyclooxygenase-2 (COX-2) Gene Promoter Polymorphism at Position −765 on Skin Cancer after Renal Transplantation

35. Five-year results of a randomized trial comparing de novo sirolimus and cyclosporine in renal transplantation: the SPIESSER study

36. Predictive diagnostic of chronic allograft dysfunction using urinary proteomics analysis

37. Efficacy and safety of early cyclosporine conversion to sirolimus with continued MMF-four-year results of the Postconcept study

38. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants

39. Diffraction techniques and vibrational spectroscopy opportunities to characterise bones

40. Evidence that graft-site candidiasis after kidney transplantation is acquired during organ recovery: a multicenter study in France

41. Influence of cyclooxygenase-2 (COX-2) gene promoter polymorphism -765 on graft loss after renal transplantation

42. G-765C COX-2 gene promoter polymorphism and risk of atherosclerosis after kidney transplantation

43. Renal function with delayed or immediate cyclosporine microemulsion in combination with enteric-coated mycophenolate sodium and steroids: results of follow up to 30 months post-transplant

44. Acute respiratory failure in kidney transplant recipients: a multicenter study